T he postulate that all peptide hormone-producing cells and all neurons are derived from the neural ectoderm 1 has led to a search for hormonal peptides and biogenic amines that are common to both the gastroenteropancreatic (GEP) system and the central nervous system. The hormones (and candidate hormones), bombesin, cholecystokinin, GIP, insulin, and VIP, first identified in the GEP system, have been detected in the brain, while the neuropeptides, neurotensin, somatostatin, substance P, TRH, and the endorphins/enkephalins, have been reported to be present in the gastrointestinal tract (for a review, see 2). The present study was designed to determine if pancreatic glucagon and/or the multiple forms of glucagon-like immunoreactive material found throughout the canine gastrointestinal tract and pancreas are identifiable in the central nervous system of the dog. 
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MATERIALS AND METHODS
For studies of the regional distribution of glucagon-like polypeptides, brains were removed from normal, fasted dogs (N = 7) immediately after killing and were washed with 0.9% saline solution; tissue samples were dissected from the following regions: (1) the medial basal hypothalamus encompassing the arcuate nucleus, the ventromedial hypothalamic area, the median eminence, and the pituitary stalk; (2) the anterior hypothalamus, encompassing the anterior hypothalamic area, the preoptic region, and the suprachiasmatic region; (3) the amygdaloid complex; (4) the mesencephalon; and (5) the occipital lobe cortex. The tissues were homogenized in 2 M ice cold acetic acid in a Teflon-glass tissue homogenizer (Glenco Scientific Inc., Houston, TX) and heated to 90° for 10 min. After centrifugation at 3000 rpm for 15 min, the supernatant was lyophilized and the residue was reconstituted in 0.2 M glycine buffer. Immunoreactive glucagon (IRG) in the extracts was measured by radioimmunoassay using antiserum 30K, which is directed against the C-terminal residues of glucagon. 3 Glucagon-like immunoreactivity (GLI) was measured using antiserum K4023 of Dr. L. Heding, which is directed against the N-terminal residues of glucagon. 4 The protein content of the extracts was measured by the method of Lowry.
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For isolation of glucagon-like polypeptides from brain and gut, the entire brain of nine normal, fasting dogs and the small intestine of two fasting dogs were removed immediately after killing, washed with water, and homogenized in ethanol-0.7 M HCI (3:1 v/v) in a Waring blender according to the method of Kenny and Say. 6 The homogenate was neutralized to pH 7.4 with 10 M sodium hydroxide solution, but the ether precipitation step was omitted. Ethanol was removed from the extract under reduced pressure at 25°, and the glucagon-like material in the extract was isolated by a previously reported technic 7 using immunoaffinity chromatography on immobilized antibodies specific for the Nterminal region of glucagon. Antibodies of this specificity were raised in rabbits by immunization with porcine pancreatic glucagon fragment, residues 1 -26 (kindly supplied by W. W. Bromer, Eli Lilly Research Center, Indianapolis), coupled covalently to bovine serum albumin. 8 The antiserum used in this study, 33D, showed approximately 300 times greater reactivity towards the 1-26 fragment of glucagon than towards the 18-29 fragment under radioimmunoassay condition and also showed strong cross-reactivity towards highly purified components of GLI isolated from porcine colon. 9 The preparation of the immunoaffinity conjugate and the procedure for affinity chromatography are described fully elsewhere. 7 Immediately before use in preparative procedures, the immunoaffinity conjugate was washed with 6 M guanadinium hydrochloride (2 vol) and with sodium phosphate buffer (pH 7.4) (20 vol) to remove endogenous glucagon-like material bound to antibody. A subsequent control elution with 1 M formic acid yielded no immunoreactivity in the eluate. The glucagon-like material purified by affinity chromatography was subjected to gel filtration on columns (60 cm x 2.5 cm) of Biogel P-10 equilibrated with 0.1 M ammonium bicarbonate buffer at pH 8.8. Amounts of IRG and GLI in the eluates were detected by radioimmunoassay.
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RESULTS
Regional distribution of IRG and GLI in dog brain.
The tissue concentrations of IRG and GLI in several areas of the brain are shown in Table 1 . Concentrations of GLI more than 100 times the plasma levels of fasted dogs were detected in the hypothalamus, amygdala, and midbrain regions. Low amounts of GLI were present in the occipital lobe cortex, also. Appreciable quantities of IRG were detected only in the hypothalamus. The distribution of GLI in canine brain is, thus, similar to the distribution of immunoreactive insulin 10 and immunoreactive somatostatin 11 in rat brain. Molecular forms of glucagon-like polypeptides in brain and gut. Over 90% of the immunoreactivity associated with the extracts of the brain and of the gut were removed by chromatography on the column of immobilized antibodies, and the immunoreactive material was subsequently recovered by irrigation of the column with 1 M formic acid. The elution profile from a Biogel P-10 gel filtration column of the immunoreactive material isolated from the brain is shown in Figure 1 . GLI (lower panel) was eluted as multiple incompletely resolved peaks with highest levels of immunoreactivity in the 8-10,000, 4-6000, and 2-3000 molecular weight zones. Consistent with the extraction data, the levels of IRG in the column eluates were much lower than those of GLI, and the IRG was eluated as a broad peak in the 3000 to 5000 molecular weight zone with maximum immunoreactivity at the elution volume of glucagon (upper panel). The corresponding elution profile of immunoreactive material isolated from the gut is shown in Figure 2 . The GLI (lower panel) was eluted as two broad peaks in the 8000 to 10,000 and 4000 to 6000 molecular weight zones. When the same fractions were assayed with a C-terminal-specific antiserum (upper panel), much lower levels of IRG, distributed in the same molecular weight regions as the GLI, were observed. The chromatographic properties of the canine gut GLIs isolated by affinity chromatography in this study are consistent with the results of previous studies 12 in which gel filtration of crude extracts of dog gut was done. The elution volumes of the 8000 to 10,000 molecular weight GLI components from both brain and gut were unchanged after incubation with 6 M guanadinium hydrochloride and so, probably, do not represent aggregates or noncovalently bound complexes of smaller immunoreactive components.
DISCUSSION
Although the 29-amino acid polypeptide, glucagon, has been identified in canine stomach 13 and pig duodenal mucosa, 14 the predominant molecular forms of glucagonlike immunoreactive material in mammalian gut react only with antibodies specific for the N-terminal region of glucagon and not with antibodies directed against the Cterminal residues of glucagon.
3 -8 These immunoreactive polypeptides differ in molecular size and charge but are believed to be biosynthetically related to glucagon 15 and may represent posttranslational modifications of a single gene product. This study has demonstrated that molecular components of GLI corresponding in size and immunologic properties to those present in extracts of canine gut are also found in extracts of several areas of canine brain, their highest concentration being in the hypothalamus. In addition, low levels of immunoreactive material that is the molecular size of glucagon and is reactive towards antibodies directed against the C-terminal region of glucagon have been found in brain but not in the gut extracts with highest concentration in the hypothalamus. In view of high proteolytic activity of brain tissue and the appreciable time required to remove and extract the brain from the killed animal, the distribution of molecular forms of GLI identified in the brain extracts may not accurately reflect their distribution in the functioning organ. In particular, the high concentration of GLI with a molecular size smaller than glucagon observed in the chromatograms of brain, but not gut, extracts may represent a degradation product of larger GLI components arising from random proteolysis during the extraction procedure. While this study was in progress, H. S. Tager (University of Chicago, personal communication) reported that rat brain also contains polypeptide material with the immunologic properties of gut GLI. Note added in proof. These studies do not differentiate between glucagon-like polypeptides synthesized locally and peptides transported in plasma and bound to brain receptors, as suggested by Eng and Yalow. 16 
